Using A Natural DNA Repair Process to Improve Genetic Medicines

RARECast - A podcast by RARECast - Joi

Podcast artwork

Categories:

Daniel Gruskin, chief medical officer of LogicBio, discusses the company’s platform technology, the advantages it provides, and the company’s lead experimental therapy for the rare metabolic condition methylmalonic acidemia.

Visit the podcast's native language site